LT - ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
EN - ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/55 |
|
|
|
A61K 31/00 |
|
|
|
A61K 9/00 |
|
|
|
A61K 9/14 |
|
|
|
A61P 25/28 |
|
|
|
A61K 9/107 |
|
European patent
| (11) |
Number of the document |
3417862 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
18186075.0 |
|
Date of filing the European patent application |
2013-07-29 |
| (97) |
Date of publication of the European application |
2018-12-26 |
| (45) |
Date of publication and mention of the grant of the patent |
2021-05-05
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
201261676348 P |
2012-07-27
|
US |
|
12178187 |
2012-07-27
|
EP |
Inventors
| (72) |
Maelicke, Alfred, DE
|
Grantee
| (73) |
Neurodyn Life Sciences Inc.,
Suite 508 NRC-INH 550 University Ave, Charlottetown C1A 4P3,
CA
|
Title
| (54) |
ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS |
| |
ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS |
